Peregrine Pharmaceuticals shares owned by Citadel Advisors
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.3M | 106k | 12.35 |
| 2024-09-30 | $15M | 1.3M | 11.38 |
| 2024-06-30 | $8.5M | 1.2M | 7.14 |
| 2024-03-31 | $12M | 1.8M | 6.70 |
| 2023-12-31 | $2.0M | 313k | 6.50 |
| 2023-09-30 | $9.9M | 1.1M | 9.44 |
| 2023-06-30 | $1.9M | 137k | 13.97 |
| 2023-03-31 | $1.3M | 70k | 18.76 |
| 2022-12-31 | $892k | 65k | 13.77 |
| 2022-06-30 | $154k | 10k | 15.25 |
| 2022-03-31 | $2.5M | 125k | 20.34 |
| 2021-12-31 | $1.3M | 45k | 29.20 |
| 2021-09-30 | $3.2M | 148k | 21.57 |
| 2021-06-30 | $2.0M | 78k | 25.67 |
| 2021-03-31 | $2.8M | 153k | 18.24 |
| 2020-12-31 | $2.1M | 182k | 11.54 |
| 2020-09-30 | $1.5M | 200k | 7.62 |
| 2020-06-30 | $351k | 53k | 6.65 |
| 2020-03-31 | $78k | 15k | 5.08 |
| 2019-12-31 | $517k | 67k | 7.67 |
| 2019-06-30 | $615k | 110k | 5.60 |
| 2019-03-31 | $73k | 17k | 4.24 |
| 2018-12-31 | $297k | 72k | 4.10 |
| 2018-09-30 | $877k | 128k | 6.84 |
| 2018-06-30 | $437k | 113k | 3.88 |
| 2018-03-31 | $189k | 65k | 2.90 |